| Literature DB >> 24266304 |
Elizabeta Topic1, Andjelo Beletic, Tomas Zima.
Abstract
INTRODUCTION: Continuing professional development (CPD) with corresponding crediting system is recognized as essential for the laboratory medicine specialists to provide optimal service for the patients. Article presents results of the survey evaluating current CPD crediting practice among members of European Federation of Clinical Chemistry and Laboratory Medicine (EFLM).Entities:
Mesh:
Year: 2013 PMID: 24266304 PMCID: PMC3900075 DOI: 10.11613/bm.2013.041
Source DB: PubMed Journal: Biochem Med (Zagreb) ISSN: 1330-0962 Impact factor: 2.313
EFLM Survey: CPD system in Europe.
|
|
| 1. Name of the National Society |
|
|
| 2. Country |
|
|
| 3. Name of the contact person |
|
|
| 4. E-mail address of the contact person |
|
|
|
|
| 5. Is there a CME/CPD programme in your country? YES / NO - National Society - Professional body (e.g. Chamber, College) - Government body (e.g. Ministry of Health or Ministry of Education) - Another organisation (please specify the name of the organisation) |
|
|
|
|
| 11. Which CME/CPD categories are evaluated in your country?
- Continuing education events (International and National congresses, courses, workshops, conference, etc.) - Distance learning (e-learning, e-seminar, teleconference) - Professional training (practical work in laboratory other than host laboratory for at least 6 months) - Activities in National Society and other professional societies - Patents in the field - Author of professional or scientific book or book chapter - Article in a professional or scientific journal - Related activities (book/journal editor, reviewer) - Supervision of specialist training, residency programs, PhD students - Other (please specify) |
|
|
|
|
| 12. Continuing education events (international and national congresses, courses, workshops, conference, etc.)
- Lecturer first author - Lecturer co-author - Participant - Organizer - Poster first author - Poster co-author |
|
|
| 13. Distance learning (e-learning, e-seminar, teleconference)
- Moderator - Lecturer - Participant |
|
|
| 14. Professional training (practical work in laboratory other than host laboratory for at least 6 months)
- In the country - Abroad |
|
|
| 15. Activities in National Society and other professional societies
- President of National Society (NS) Executive Board - Member of NS Executive Board, Committees, Working Groups (WGs), Task Finishing Groups (TFGs) - President of EFCC Executive Board - Member of EFCC Executive Board, Committees, WGs, TFGs - President of IFCC Executive Board - Member of IFCC Committees, WGs, TFGs - Another activity (please specify) |
|
|
| 16. Patents in the field |
|
|
| 17. Author of professional or scientific book or book chapter
- First author - Co-authors |
|
|
| 18. Article in a professional or scientific journal
- First author - Co-authors |
|
|
| 19. Related activities
- Book Editor - Journal Editor - Reviewer of books or journal articles - Other (please specify) |
|
|
| 20. Supervision of specialist training, residency programs, PhD students |
European countries which participated in the EFLM survey (N = 28).
| 1. Albania |
| 2. Belgium |
| 3. Bosnia and Herzegovina |
| 4. Bulgaria |
| 5. Croatia |
| 6. Cyprus |
| 7. Czech Republic |
| 8. Denmark |
| 9. Estonia |
| 10. Finland |
| 11. France |
| 12. Greece |
| 13. Iceland |
| 14. Ireland |
| 15. Israel |
| 16. Italy |
| 17. Lithuania |
| 18. Netherlands |
| 19. Poland |
| 20. Russia |
| 21. Serbia |
| 22. Slovak Republic |
| 23. Slovenia |
| 24. Spain |
| 25. Sweden |
| 26. Switzerland |
| 27. UK |
| 28. Ukraine |
Answers on questions 5, 6 and 7.
| Yes (N = 23) | Albania, Belgium, Bulgaria, Croatia, Czech Republic, Estonia, Finland, France, Greece, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Russia, Serbia, Slovak Republic, Slovenia, Spain, Switzerland, UK, Ukraine |
| No (N = 5) | Bosnia and Herzegovina, Cyprus, Denmark, Iceland, Sweden |
| Yes (N = 23) | Albania, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, France, Greece, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Serbia, Slovak Republic, Slovenia, Spain, Switzerland, Ukraine, UK |
| No (N = 5) | Bosnia and Herzegovina, Denmark, Iceland, Russia, Sweden |
| Yes (N = 19) | Belgium, Cyprus, Czech Republic, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Russia, Serbia, Slovak Republic, Spain, Sweden, Switzerland, Ukraine, UK |
| No (N = 9) | Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Denmark, Greece, Iceland, Poland, Slovenia |
FIGURE 1Who evaluates the CME/CPD events?
Relationship between participation in CPD activities in licensing and relicensing of specialists in laboratory medicine.
| Yes (N = 22) | Albania, Belgium, Bosnia and Herzegovina, Croatia, Cyprus, Czech Republic, Estonia, Finland, France, Iceland, Ireland, Israel, Netherlands, Poland, Russia, Serbia, Slovak Republic, Slovenia, Spain, UK, Ukraine, Switzerland |
| No (N = 6) | Bulgaria, Denmark, Greece, Italy, Lithuania, Sweden |
| Yes (N = 13) | Albania, Bosnia and Herzegovina, Croatia, Czech Republic, Estonia, Netherlands, Poland, Russia, Serbia, Slovak Republic, Slovenia, UK, Ukraine |
| No (N = 15) | Belgium, Bulgaria, Cyprus, Denmark, Finland, France, Greece, Iceland, Ireland, Israel, Italy, Lithuania, Spain, Sweden, Switzerland |
Categories recognised for CME/CPD in different countries (N = number of countries).
| Albania | ||||||||
| Belgium | ||||||||
| Bosnia & Herzegovina | ||||||||
| Bulgaria | ||||||||
| Croatia | ||||||||
| Czech Republic | ||||||||
| Estonia | ||||||||
| Finland | Albania | |||||||
| France | Belgium | |||||||
| Greece | Croatia | |||||||
| Ireland | Czech Republic | Albania | Albania | |||||
| Israel | Estonia | Croatia | Croatia | |||||
| Italy | France | Czech Republic | Czech Republic | |||||
| Lithuania | Ireland | Estonia | Estonia | Albania | Croatia | |||
| Netherlands | Italy | Ireland | France | Bulgaria | Estonia | |||
| Poland | Lithuania | Lithuania | Ireland | Croatia | Finland | |||
| Russia | Netherlands | Netherlands | Italy | Czech Republic | France | |||
| Serbia | Poland | Poland | Netherlands | Estonia | Ireland | Croatia | ||
| Slovak Republic | Russia | Russia | Poland | Ireland | Italy | Estonia | Croatia | |
| Slovenia | Serbia | Serbia | Serbia | Netherlands | Russia | Ireland | Estonia | |
| Spain | Slovak Republic | Slovak Republic | Spain | Serbia | Serbia | Italy | Ireland | Croatia |
| Switzerland | Slovenia | Slovenia | Switzerland | Spain | Slovak Republic | Lithuania | Poland | Czech |
| UK | UK | UK | UK | Switzerland | UK | Slovak Republic | Serbia | Republic |
| Ukraine | Ukraine | Ukraine | Ukraine | UK | Ukraine | UK | UK | Ukraine |
Scores allocated to CPD categories and sub-categories, in accordance with appreciation of their importance.
| Continuing education events (international and national congresses, courses, workshops, conference, etc.) | 10 (2.5–15.0); 10 |
| - Lecturer first author | 20 (10.0–30.0); 30 |
| - Lecturer co-author | 9 (3.0–15.0); 15 |
| - Participant | 5 (1.0–12.5); 1 |
| - Organizer | 10 (1.0–15.0); 15 |
| - Poster first author | 10 (5.0–16.5); 10 |
| - Poster co-author | 5 (1.5–10.0); 5 |
|
| |
| Distance learning (e-learning, e-seminar, teleconference) | 10 (3.5–20.0); 30 |
| - Moderator | 12 (4.5–20.0); 20 |
| - Lecturer | 15 (6.5–27.5); 30 |
| - Participant | 6 (2.0–12.5); 10 |
|
| |
| Professional training (practical work in laboratory other than host laboratory for at least 6 months) | 20 (11.0–30.0); 30 |
| - In the country | 20 (10.0–25.0); 20 |
| - Abroad | 20 (10.0–30.0); 30 |
|
| |
| Activities in National Society and other professional societies | 20 (5.0–25.0); 30 |
| - President of National Society (NS) Executive Board | 20 (6.5–30.0); 30 |
| - Member of NS Executive Board, Committees, Working Groups (WGs), Task Finishing Groups (TFGs) | 10 (5.0–20.0); 10 |
| - President of EFCC Executive Board | 25 (6.5–30.5); 30 |
| - Member of EFCC Executive Board, Committees, WGs, TFGs | 15 (5.0–20.0); 20 |
| - President of IFCC Executive Board | 25 (6.5–30.0); 30 |
| - Member of IFCC Committees, WGs, TFGs | 15 (5.0–20.0); 20 |
|
| |
| Patents in the field | 15 (1.0–30.0); 30 |
|
| |
| Author of professional or scientific book or book chapter | 20 (8.0–30.0); 30 |
| - First author | 30 (20.0–30.0); 30 |
| - Co-authors | 15 (10.0–21.5); 10 |
|
| |
| Article in a professional or scientific journal | 15 (10.0–24.0); 20 |
| - First author | 20 (10.0–30.0); 30 |
| - Co-authors | 11 (5.0–20.0); 10 |
|
| |
| Related activities | 20 (9.0–30.0); 30 |
| - Book Editor | 20 (9.0–30.0); 30 |
| - Journal Editor | 20 (14.5–30.0); 30 |
| - Reviewer of books or journal article | 10 (5.0–16.5); 10 |
|
| |
| Supervision of specialist training, residency programs, PhD students | 15 (5.0–20.0); 20 |
Q1–Q3-interquartile range, Q1-1st quartile, Q3-3rd quartile
- Polymodal distribution was observed, other mode values were 5, 10, 20.
- Bimodal distribution was observed, other mode value was 2.